Akero Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Akero Therapeutics

Access the complete profile.

Akero Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	601 Gateway Blvd Suite 350 South San Francisco, CA 94080

Note: Revenues for privately held companies are statistical evaluations.


Akero Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Akero Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Akero Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Akero Therapeutics Annual Revenue and Growth Rate

Akero Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Akero Therapeutics's revenues are gauged from an analysis of company filings.

Akero Therapeutics's Income Statement (based on Industry Averages)

Akero Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Akero Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
December 18, 2018	20	100%	$45 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Akero Therapeutics is developing and marketing. Akero Therapeutics doesn't have any recent trademark applications, indicating Akero Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
AKERO Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis (NASH), fibrosis, inflammatory and autoimmune disorders, cirrhosis, metabolic diseases, cardiovascular diseases, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis, retinal and neurodegenerative and other related diseases and disorders; Pharmaceutical preparations for the treatment of fatty liver diseases and disorders and Steatohepatitis and other related diseases and disorders	08/22/2018
PIPPIN Research and development of human therapeutics; pharmaceutical research and development services	05/17/2017

See all trademarks and details in the Full Report.

Market Share of Akero Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Akero Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Akero Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
EMERALD THERAPEUTICS	South San Francisco, CA	100
PHARMACYCLICS	Sunnyvale, CA	59
ALTOS LABS	Redwood City, CA	39
NURO	Mountain View, CA	30
SRI INTERNATIONAL	Menlo Park, CA	27
EXPONENT	Menlo Park, CA	21

Other Companies at 601 Gateway Blvd, South San Francisco CA

Company	Headquarters	Revenue ($ MM)
AXIA VEGETABLE SEEDS GROUP	South San Francisco, CA	100
RACE TECHNOLOGIES	S San Fran, CA	64
QUINCE THERAPEUTICS	South San Francisco, CA	8
SIMPSON GARRITY INNES & JACUZZI APC	South San Francisco, CA	8
OUTPOST GAMES	South San Francisco, CA	1

Future Competition: Akero Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Akero Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)